PreveCeutical Medical Inc. PREV
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.91% | -38.45% | |||
| Depreciation & Amortization | 0.00% | 15.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.88% | -43.23% | |||
| Operating Income | 0.88% | 43.23% | |||
| Income Before Tax | 0.89% | -146.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.89% | -146.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.89% | -142.57% | |||
| EBIT | 0.88% | 43.23% | |||
| EBITDA | 0.89% | 43.54% | |||
| EPS Basic | 14.29% | -143.75% | |||
| Normalized Basic EPS | 0.00% | 20.00% | |||
| EPS Diluted | 14.29% | -143.75% | |||
| Normalized Diluted EPS | 0.00% | 20.00% | |||
| Average Basic Shares Outstanding | 0.00% | 1.34% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||